Preclinical data from the biotech firm Peptron (& collaborators) reports that the GLP-1 receptor agonist PT320 attenuates L-DOPA/benserazide-induced dyskinesia in a 6-OHDA rodent model of #Parkinsons https://t.co/Ff3c57H2jB https://t.co/6eVzRm8NCW
10,545 followers
335 followers
RT @FrontNeurosci: New Research: PT320, Sustained-Release Exendin-4, Mitigates L-DOPA-Induced Dyskinesia in a Rat 6-Hydroxydopamine Model o…
75,844 followers
New Research: PT320, Sustained-Release Exendin-4, Mitigates L-DOPA-Induced Dyskinesia in a Rat 6-Hydroxydopamine Model of Parkinson’s Disease: Background We previously demonstrated that subcutaneous administration of PT320, a… https://t.co/ucG7Yvmjm0 #Neur